- Home
- TMO vs NVS Comparison
TMO vs NVS Comparison
Compare TMO & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMO
- NVS
- Stock Information
- Founded
- TMO 1956
- NVS 1895
- Country
- TMO United States
- NVS Switzerland
- Employees
- TMO N/A
- NVS N/A
- Industry
- TMO Industrial Machinery/Components
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- TMO Industrials
- NVS Health Care
- Exchange
- TMO Nasdaq
- NVS Nasdaq
- Market Cap
- TMO 216.4B
- NVS 254.8B
- IPO Year
- TMO N/A
- NVS 1991
- Fundamental
- Price
- TMO $592.32
- NVS $130.63
- Analyst Decision
- TMO Buy
- NVS Sell
- Analyst Count
- TMO 17
- NVS 3
- Target Price
- TMO $611.19
- NVS $118.00
- AVG Volume (30 Days)
- TMO 1.7M
- NVS 1.7M
- Earning Date
- TMO 10-22-2025
- NVS 10-28-2025
- Dividend Yield
- TMO 0.29%
- NVS 1.99%
- EPS Growth
- TMO 8.54
- NVS N/A
- EPS
- TMO 17.32
- NVS 7.30
- Revenue
- TMO $43,736,000,000.00
- NVS $56,372,000,000.00
- Revenue This Year
- TMO $4.28
- NVS $9.44
- Revenue Next Year
- TMO $5.00
- NVS $2.65
- P/E Ratio
- TMO $34.26
- NVS $17.88
- Revenue Growth
- TMO 3.22
- NVS 12.88
- 52 Week Low
- TMO $385.46
- NVS $96.06
- 52 Week High
- TMO $610.97
- NVS $134.00
- Technical
- Relative Strength Index (RSI)
- TMO 65.64
- NVS 56.19
- Support Level
- TMO $556.46
- NVS $123.24
- Resistance Level
- TMO $602.32
- NVS $133.19
- Average True Range (ATR)
- TMO 14.02
- NVS 1.78
- MACD
- TMO -0.22
- NVS 0.12
- Stochastic Oscillator
- TMO 80.42
- NVS 67.75
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.